• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtech stories we missed this week: Oct. 20, 2017

October 20, 2017 By Danielle Kirsh

missed medtech
[Image from unsplash.com]
From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention.

1. InspireMD inks Chile distribution deal

InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime Embolic Protection System (EPS). The MGuard Prime EPS treats acute coronary syndromes like acute myocardial infarctions.

2. Medacta launches MiniMed hip stem

Medacta has launched its MiniMAX Hip System in the U.S., according to an Oct. 12 press release. MiniMAX is an anatomical cementless stem that is engineered to provide enhanced fit and fill in the metaphyseal femur. It follows the natural shape of the femoral canal for minimally-invasive anterior and posterior hip replacement procedures.

3. Esaote launches MyLab 9 ultrasound

Esaote announced in an Oct. 13 press release that it has launched its MyLab 9 ultrasound platform. MyLab 9 has smart upgradability, remote serviceability, long-term maintenance options and transducer compatibility.

Get the full story on our sister site, MassDevice.

Filed Under: Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Hospital Care, Imaging, Orthopedics, Patient Monitoring, Regulatory/Compliance, Surgical Tagged With: Esaote, Hill-Rom Holdings Inc., Honeywell, InspireMD, Medacta, medtech, RenalGuard Solutions, Subchondral Solutions, Vivasure, Welch Allyn

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS